BioCentury
ARTICLE | Clinical News

Symbicort budesonide/formoterol regulatory update

October 19, 2009 7:00 AM UTC

Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA from AstraZeneca for Symbicort Turbuhaler budesonide/formoterol for the maintenance treatment of asthma in patients ages 16 and up....